| Last Price | 65.80 | Max Price | 78.30 |
| Min Price | 49.40 | 1 Year return | -26.15 |
| Sector | Health Care | Subsector | Pharmaceuticals |
| Year | Turnover | Total sector | Market share |
|---|---|---|---|
| 2019 | 29 | 474,848 | 0.01 % |
| 2020 | 24 | 469,560 | 0.01 % |
| 2021 | 36 | 566,739 | 0.01 % |
| 2022 | 38 | 640,095 | 0.01 % |
| 2023 | 45 | 590,728 | 0.01 % |
No Records Found
No Records Found
No Records Found
Over the last 12 months, that were profitable period for the investors in Photocure, the stock gained around 19 percent. The period between August 2011 and August 2016 was a good period for the investors. The stock rose around 46 percent.
Photocure's core business is the pharmaceutical sector. The period from 2006 till the end of 2016 the international sector gained around 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.
Photocure didn't pay out any dividends (in the past 5 years).
At the end of 2015 the Norwegian company had a balance sheet of around 0 million NOK. Last year the total debt of the company was 0 million NOK. This equals around percent of the total balance sheet.
All Photocure's financial reports are located here. More information about Photocure can be found it's website. .
| Results |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Revenue |
|
|
|
|
|
| Costs |
|
|
|
|
|
| Profit |
|
|
|
|
|
| Margin of profit |
|
|
|
|
|
| ROI |
|
|
|
|
|
| Balance |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Equity |
|
|
|
|
|
| Debt |
|
|
|
|
|
| Total assets |
|
|
|
|
|
| Solvency |
|
|
|
|
|
| Cash |
|
|
|
|
|
| Cashflow |
|
|
|
|
|
| Employees |
|
|
|
|
|
| Revenue per employee |
|
|
|
|
|
| Cashflow / Debt |
|
|
|
|
|
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Price |
42.00
|
27.30
|
48.00
|
89.50
|
106.60
|
| Eps |
0.18
|
-0.16
|
-0.17
|
0.15
|
-0.09
|
| Price/earnings-ratio |
233.33
|
-170.62
|
-282.35
|
596.67
|
-731.11
|
| Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
| Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Book value |
1.29
|
1.03
|
0.82
|
0.97
|
1.82
|
| Market to book |
0.03
|
0.04
|
0.02
|
0.01
|
0.03
|
| Cashflow per stock |
0.10
|
-0.11
|
-0.11
|
0.10
|
0.06
|
| Stocks |
22
|
22
|
22
|
22
|
27
|
| Market Cap |
905.40
|
588.51
|
1.044.68
|
1.949.29
|
1.756.99
|
|
Date
|
Price
|
|---|---|
|
01 May 2026
|
65.80
|
|
28 Apr 2026
|
69.80
|
|
21 Apr 2026
|
65.70
|
|
14 Apr 2026
|
63.10
|
|
01 Apr 2026
|
59.30
|
|
30 Mar 2026
|
63.70
|
|
28 Mar 2026
|
63.70
|
|
25 Mar 2026
|
63.30
|
|
24 Mar 2026
|
61.70
|
|
19 Mar 2026
|
64.20
|
|
17 Mar 2026
|
67.30
|
|
10 Mar 2026
|
71.10
|
|
08 Mar 2026
|
69.90
|
|
03 Mar 2026
|
72.70
|
|
24 Feb 2026
|
58.70
|
|
10 Feb 2026
|
65.70
|
|
06 Feb 2026
|
66.00
|
|
04 Feb 2026
|
69.00
|
|
28 Jan 2026
|
71.70
|
|
26 Jan 2026
|
72.40
|
|
21 Jan 2026
|
73.20
|
|
17 Jan 2026
|
78.30
|
|
13 Jan 2026
|
77.40
|
|
21 Dec 2025
|
68.40
|
|
18 Dec 2025
|
66.00
|
|
17 Dec 2025
|
65.50
|
|
16 Dec 2025
|
64.70
|
|
15 Dec 2025
|
67.10
|
|
11 Dec 2025
|
66.50
|
|
10 Dec 2025
|
65.70
|